The licensed cultivator and manufacturer of medical cannabis products, Tropizen, is aiming to expand its business in Puerto Rico, relaunching its cannabis-based edibles line. These products come in a variety of forms and sizes, but the most popular are the gummies, made only with natural ingredients, which allow cannabis patients across the island to consume their daily doses easily.
Products with CBD, recognized in Mexico by Cofepris and booming on the mainland, are also on strong demand on the islands of Central America and the Caribbean. Now Tropizen, a medical cannabis manufacturer, is betting on marketing its products in Puerto Rico.
Tropizen announced the launch of its medical cannabis products line, incorporating new products, aimed at cannabis patients who are looking for an easy way to consume their daily doses.
Furthermore, the company has put in motion a plan to add additional ingredients to the products that also provide health benefits, with improved flavors which would help catch the attention of both existing and new customers.
If you want to know more about cannabis, how Tropizen is marketing their medical cannabis products in Puerto Rico, and to find out the latest hemp news, download the Hemp.im mobile application.
The demand of cannabis-based products is higher than ever before
According to the latest data, the volume of grocery production at Tropizen has increased by approximately 60 percent to meet the demand for the new products. Despite this, the initial production has already been completely sold to dispensaries throughout the island, which serve as an indication of the vast amount of people interested in cannabis and cannabis-based products.
The new cannabis gummies, produced locally at the company’s manufacturing facility in Canóvanas, will be marketed under the brand name “Tropizen Superfruit Gummies” and will include new varieties and also natural flavors such as guava and mango.
The company has stated that its new products are made with only natural ingredients, using primarily fruit harvested by Puerto Rican farmers in order to boost the local cannabis industry even more.
“The gummies will have a new and distinctive shape, with the image of a sea wave, which evokes the spirit of the brand and complements the design of a palm that forms part of the company logo,” explained Meistrell, co-founder of Tropizen.
Tropizen is hiring more people to expand its cannabis business
Meistrell explained that even in the midst of the coronavirus pandemic, which has forced many companies to cut expenses and jobs, Tropizen continues to recruit people with or without experience that are interested in the cannabis sector, in order to increase its resources dedicated to cannabis manufacturing and cultivation.
It is estimated that Tropizen employment rate is currently almost 30 percent higher than at the beginning of the year, which is an achievement considering the current economic crisis that’s enveloping the world.
“The steps we have taken to continually improve our products, particularly gummies, demonstrate our commitment to innovation and the development of the highest quality medical cannabis products,” Meistrell said, assuring that the company will keep its policy no matter the global situation.
Cannabis businessmen are asking the Government to support the cannabis sector
A few weeks ago, the Puerto Rican medical cannabis industry asked government authorities to participate in the process of amending regulatory law. MICaM, as the group of firms in the field is called, indicated that the legislature did not consider the industry’s input.
The Association of Members of the Medical Cannabis Industry (MICaM), expressed concern about the early approval of bills that seek to amend the law regulating this industry in Puerto Rico, without the input of the industry.
Companies like Tropizen are developing and expanding their business, establishing a customer base that could help give the necessary feedback that the government needs in order to make the right decisions.
Among those proposals is Senate Bill 1317, which was before the House of Representatives and was approved with amendments by that body, so it will be evaluated in a Conference Committee during the next few days.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Hemp.im, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in La Marihuana, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.